Pacira BioSciences (PCRX) Gross Margin (2010 - 2026)
Pacira BioSciences (PCRX) posted quarterly Gross Margin of 79.47% for Q1 2026, down 22.0% year-over-year from 101.89% in Q1 2025, and little changed quarter-over-quarter from 79.53% in Q4 2025.
Pacira BioSciences (PCRX) Gross Margin (2010 - 2026) Analysis & Trends
Pacira BioSciences' Gross Margin history runs 17 years deep, the most recent figure standing at 79.47% for Q1 2026.
- In Q1 2026, Gross Margin fell 22.0% year-over-year to 79.47%; the TTM figure through Mar 2026 stood at 79.34% (up 172.0% YoY), while the FY2025 annual figure was 79.39%, up 370.0% from the prior year.
- Gross Margin for Q1 2026 stood at 79.47%, roughly flat from 79.53% in the prior quarter.
- The five-year high for Gross Margin was 112.58% in Q4 2022, with the low at 69.43% in Q1 2023.
- The 5-year median for Gross Margin is 76.95% (2024), against an average of 77.62%.
- The sharpest annual moves came in 2022 and 2023: Gross Margin jumped 3708 bps in 2022, then sank 3889 bps in 2023.
- Pacira BioSciences' Gross Margin stood at 112.58% in 2022, then sank by 35 bps to 73.69% in 2023, then advanced by 7 bps to 78.7% in 2024, then climbed by 1 bps to 79.53% in 2025, then fell by 0 bps to 79.47% in 2026.
- Business Quant data shows PCRX's Gross Margin at 79.47% in Q1 2026, 79.53% in Q4 2025, and 80.91% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Pacira BioSciences | 945.51 Mn | 694.48 Mn | 148.24 Mn | 77.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 77.05% |
| Mar 31, 2026 | 79.47% |
| Dec 31, 2025 | 79.53% |
| Sep 30, 2025 | 80.91% |
| Jun 30, 2025 | 77.43% |
| Mar 31, 2025 | 79.69% |
| Dec 31, 2024 | 78.70% |
| Sep 30, 2024 | 76.95% |
| Jun 30, 2024 | 75.14% |
| Mar 31, 2024 | 71.63% |
| Dec 31, 2023 | 73.69% |
| Sep 30, 2023 | 75.75% |
| Jun 30, 2023 | 71.55% |
| Mar 31, 2023 | 69.43% |
| Dec 31, 2022 | 112.58% |
| Sep 30, 2022 | 69.74% |
| Jun 30, 2022 | 70.12% |
| Mar 31, 2022 | 77.17% |
| Dec 31, 2021 | 75.50% |
| Sep 30, 2021 | 72.87% |